A clinical study at the Arizona Cancer Center aims to find out whether a green-tea extract can halt the development of cervical cancer. For four months, subjects infected with human papillomavirus will ingest daily either a placebo or an 800-milligram capsule of the green-tea extract known as Polyphenon E.

Related Summaries